Biopharmaceutical Company at Stage Clinique Aardvark Therapeutics (Unard)) Dear Its IPO of around 5.89 million shares at $ 16.00 per share. All actions are proposed by Aardvark.
The California -based startup plans to use the product to support the development of hunger removal drugs for the